Trial
NCT00102154
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Insomnia
Intervention
MK0928, gaboxadol / Duration of Treatment: 10 months
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-01-14